Line 3,587: | Line 3,587: | ||
</h4> | </h4> | ||
</div> | </div> | ||
− | <ul | + | <ul> |
<li style="text-align:justify">He brought common mistakes in <b>disposal of pharmaceuticals</b> to our attention. In most regions | <li style="text-align:justify">He brought common mistakes in <b>disposal of pharmaceuticals</b> to our attention. In most regions | ||
it is sufficient to dispose them in household waste, but in others they must be handed in at | it is sufficient to dispose them in household waste, but in others they must be handed in at | ||
Line 3,604: | Line 3,604: | ||
</h4> | </h4> | ||
</div> | </div> | ||
+ | <ul> | ||
+ | |||
<li style="text-align:justify">In order to bring the information about proper disposal of pharmaceuticals to the public, | <li style="text-align:justify">In order to bring the information about proper disposal of pharmaceuticals to the public, | ||
we have translated the <b>flyer from the German Federal Environmental Agency</b> into English, in | we have translated the <b>flyer from the German Federal Environmental Agency</b> into English, in | ||
Line 3,613: | Line 3,615: | ||
to use drugs in the process of recovery, but excessive consumption leads to environmental | to use drugs in the process of recovery, but excessive consumption leads to environmental | ||
pollution and species extinction.[5]</li> | pollution and species extinction.[5]</li> | ||
+ | </ul> | ||
<br><br> | <br><br> | ||
Revision as of 14:25, 11 October 2020
Why did we talk to him?
- Patrick Schröder is a research assistant at the German Federal Environmental Agency.
- He is specified on biodegradation of pharmaceuticals and the development of antimicrobial resistances in the environment.
Which information did we gather?
- He brought common mistakes in disposal of pharmaceuticals to our attention. In most regions it is sufficient to dispose them in household waste, but in others they must be handed in at special collection points or pharmacies.
- He also told us about particularly pharmaceuticals that cause an immense burden on the environment. These include ibuprofen and hormones like estrogen, since they pose dangers to aquatic flora and fauna and are still used by most of us on a regular basis.
- Furthermore, he pointed out that diclofenac, a substance that we focus our attention on, has never received an environmental risk assessment as of today and is nevertheless used by the general public without hesitation.
How did we adjust our project?
- In order to bring the information about proper disposal of pharmaceuticals to the public, we have translated the flyer from the German Federal Environmental Agency into English, in order to sensitize people internationally.
- We also decided to take a closer look at the degradation of estrogen and ibuprofen by laccases. Since laccases also show dismantling of both substances, we try to make our contribution here.
- Our goal is to educate the average citizen. If illness or symptoms exist, it is unevitable to use drugs in the process of recovery, but excessive consumption leads to environmental pollution and species extinction.[5]
text über Prof. Dr. Jörg Oehlmann
Why did we talk to him?
What information did we gather?
How did we adjust our project?
bla bla
Why did we talk to him?
PhD Yunrong Chai is an assistant professor at the College of Science at the Northeastern University in Boston and an expert for microbial genomics and biofilm formation. We talked to him about our ideas to engineer and improve our biofilm.
Which information did we gather?
How did we adjust our project?
We continued planning our fusion proteins with TasA and the knockout of sinR. Additionally, we integrated the knockout of σF into our project to avoid sporulation of our B. subtilis.Why did we talk to her?
What information did we gather?
How did we adjust our project?
For a more detailed review on her input, please CLICK HERE.
noch einfügen
noch einfügen
Why did we talk to him?
In order to implement our biofilm into wastewater treatment plants (WWTP) we have to deal with legal requirements in Germany. Therefore, the team from Kaiserslautern had the idea to contact Dr. Ulrich Ehlers from the Federal Office for Consumer Protection and Food Safety (BVL) and since we are working close together, we were able to ask him a few questions. He has been the head of the "release and placing on the market" section in the BVL’s "Genetic Engineering" department.
Which information did we gather?
How did we adjust our project?
We know whom we have to contact, if we plan to implement our system into the first WWTP. We have also put our focus more on designing a kill switch, which would help us working in content use and getting a WWTP classified as genetic engineering plant
noch einfügen
Visit of a WWTP
Since our project is to be integrated into wastewater treatment plants in the future, we wanted to have a first-hand look at such a plant. For that, we visited the wastewater treatment plant from ENTEGA in Darmstadt. This visit gave us the opportunity to see by ourselves how wastewater treatment can work and which steps are necessary to achieve a clean outcome. We learned how different waste water treatment plants can be and how differently they have to deal with new guidelines concerning the quality of the treated wastewater. The wastewater treatment plant in Darmstadt is built of a primary treatment clarifier, followed by a biological wastewater treatment and a final clarifier.
For the implementation of our biofilm, a new clarifier for an additional purification stage would be necessary in the mentioned wastewater treatment plant. Space for another tank in this plant is available but we have to consider that especially wastewater treatment plants in bigger cities wouldn’t have enough space for this. Considering this issue, we thought about different options to implement our project (link Biofilm in chemischer Stufe, Filmis).
noch einfügen
noch einfügen
noch einfügen